MJN68390

CAS No. 1956368-39-0

MJN68390( —— )

Catalog No. M36320 CAS No. 1956368-39-0

MJN68390 has an apparent IC50 value of 15 μM against CASP8 and shows no activity against CASP10.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 459 Get Quote
10MG 657 Get Quote
25MG 994 Get Quote
50MG 1371 Get Quote
100MG 1773 Get Quote
500MG 3537 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MJN68390
  • Note
    Research use only, not for human use.
  • Brief Description
    MJN68390 has an apparent IC50 value of 15 μM against CASP8 and shows no activity against CASP10.
  • Description
    MJN68390 has an apparent IC50 value of 15 μM against CASP8 and shows no activity against CASP10.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Caspase
  • Recptor
    Caspase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1956368-39-0
  • Formula Weight
    441.95
  • Molecular Formula
    C24H28ClN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C(CCl)=O)([C@H]1CN(C(=O)C2=CC=C(C=C2)N3CCOCC3)CCC1)C4=CC=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Cystamine

    Cystamine (2,2'-Disulfanediyldiethanamine) is an inhibitor of transglutaminase and inhibits caspase-3 with an IC50 value of 23.6 μM. Cystamine can be used in studies about Huntington's diseases.

  • M50054

    Apoptosis Inhibitor was a novel inhibitor of programmed cell death associate with caspase-3 inhibition.

  • Ac-FLTD-CMK

    Ac-FLTD-CMK is an inhibitor derived from abscisicin D (GSDMDD) with specific inhibitory effects on inflammatory caspases. ac-FLTD-CMK showed inhibitory effects on caspases-1, caspases-4 and caspases-11 with IC50s of 46.7 nM, 1.49 μM and 329 nM, respectively. Ac-FLTD-CMK showed potency against caspases-1, caspases-4 and caspases-11, but not against apoptosis-associated caspase-3.